BrainsWay Stock Gains On FDA Expanded Use Approval For Its Stimulation Device
The FDA has cleared BrainsWay Ltd’s (NASDAQ:BWAY) Deep Transcranial Magnetic Stimulation (Deep TMS) System to reduce comorbid anxiety symptoms in adult…
HC Wainwright & Co. Maintains Buy on BrainsWay, Lowers Price Target to $14
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and lowers the price target from $17 to $14.
Brainsway Q2 EPS $(0.06) Down From $(0.03) YoY, Sales $7.00M Beat $6.19M Estimate
Brainsway (NASDAQ:BWAY) reported quarterly losses of $(0.06) per share. This is a 100 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $7.00
Earnings Scheduled For August 11, 2021
Companies Reporting Before The Bell
• Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.
HC Wainwright & Co. Initiates Coverage On BrainsWay with Buy Rating, Announces Price Target of $17
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on BrainsWay (NASDAQ:BWAY) with a Buy rating and announces Price Target of $17.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 188 stocks made new 52-week highs.
Earnings Scheduled For May 20, 2021
Companies Reporting Before The Bell
• Meten EdtechX Education (NASDAQ:METX) is expected to report earnings for its first quarter.
Stocks That Hit 52-Week Highs On Wednesday
During the morning session on Wednesday, 398 stocks hit new 52-week highs. Interesting Highlights: Alphabet (NASDAQ:GOOGL) was the largest company…